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Genetic studies and other experimental data have linked inflammatory bowel diseases with inflammasome
activation. In this issue of Immunity, Zaki et al. (2010) and Dupaul-Chicoine et al. (2010) provide a detailed
characterization of the regulatory task of the inflammasome in intestinal epithelial cells.Activation of the NLRP3 inflammasome
results in the conversion of pro-caspase-1
to caspase-1 followed by the cleavage
of pro-interleukin-1b (pro-IL-1b) and pro-
IL-18 to their active cytokines. Gain-of-
function mutations within NLRP3 have
been associated with various autoinflam-
matory disorders, such as the Muckle-
Wells syndrome (MWS), familial cold
autoinflammatory syndrome (FCAS), and
neonatal-onset multisystem inflammatory
disease (NOMID). These hereditary peri-
odic fever syndromes are characterized
by skin rashes, periodic fever, and arthritis
and are now lumped together and called
cryopyrin-associated periodic fever syn-
dromes (CAPS). Anti-IL-1b is uniquely
effective in treating CAPS, thus empha-
sizing the central role of the NLRP3 (Dinar-
ello, 2004). These findings led to the
assumption that other autoinflammatory
disorders such as inflammatory bowel
diseases might equally be a consequence
of NLRP3 inflammasome activation.
For inflammatory bowel diseases, first
evidence was provided in 1999 by Pizarro
et al. (1999). This study revealed an upre-
gulation of IL-18 in the intestine of Crohn’s
disease patients with a higher expression
in active disease and a localization of
IL-18 synthesis in intestinal epithelial cells
(IECs) as well as macrophages and den-
dritic cells (DCs) in the lamina propria.
Immunoblot analysis confirmed that ma-
ture and thus active IL-18 and not the
constitutively expressed precursor was
present. Functional data followed this
initial descriptive study indicating that
mice were protected in various models
of colitis, including dextran sulfate sodium
(DSS)- and trinitrobenzene sulphonic acid
(TNBS)-induced colitis, when either pro-
IL-18 could not be activated or the active
cytokine was neutralized via antibody300 Immunity 32, March 26, 2010 ª2010 Else(Kanai et al., 2001; Siegmund et al.,
2001). In agreement with the human
data, IL-18 production was localized to
IECs and macrophages or DCs of the
lamina propria. At that time, one could
conclude that neutralization of IL-18
should be beneficial for intestinal inflam-
mation. However, subsequently, the con-
cept became questionable. Although
blocking IL-18 in experimental models of
colitis was effective, genetic data sug-
gested that SNPs in the NLRP3 region
contribute to Crohn’s disease suscepti-
bility. The SNPs are associated with a
decrease of NLRP3 mRNA expression
(Villani et al., 2009). In theory, a decrease
of NLRP3 is followed by a decrease in
NLRP3 inflammasome activation and
consecutively a decrease in IL-1b and
IL-18. Together these data indicated that
the regulation of intestinal inflammation
by the NLRP3 inflammasome is more
complex. In fact, functional studies for
intestinal inflammation focusing on the
NLRP3 inflammasome were lacking. This
issue of Immunity provides data that allow
for a novel working hypothesis (Figure 1).
Zaki et al. (2010) in this issue of Immu-
nity subjected Nlrp3/ mice to experi-
mental colitis with DSS, which resulted
in increased mortality as well as macro-
scopic and histologic signs of colitis
when compared to wild-type (WT) mice.
Similar susceptibility was observed for
mice deficient in the inflammasome com-
ponent ASC (Pycard/) and in caspase 1
(Casp1/). Because the Nlrp3 inflamma-
some activation is prerequisite for either
IL-1b or IL-18 activation, it is not sur-
prising that IL-18 is upregulated at the
site of inflammation in DSS-exposed
WT but not in Nlrp3/, Pycard/, and
Casp1/ mice. A key role could be as-
signed to IL-18 because disease deterio-vier Inc.ration could be reversed by the adminis-
tration of IL-18. To define the relevant
cell population, bone marrow chimera
were generated, indicating that nonhema-
topoietic cells are critical for the increased
susceptibility. Considering these results
in view of earlier data, the epithelial cells
and thus the epithelial barrier are likely to
play a crucial role. The critical function of
the epithelial cells is the maintenance of
the epithelial barrier. After DSS exposure,
an increase in intestinal barrier perme-
ability could be observed in Nlrp3/
and Casp1/ compared to WT mice by
FITC-dextran. Similarly, bacterial translo-
cation was elevated in these animals and
furthermore, antibiotics treatment pro-
tected from DSS-induced morbidity and
mortality. As a mechanism behind this
defect, epithelial cell proliferation was
higher in DSS WT than in DSS Nlrp3/
and Casp1/ mice, suggesting that
Nlrp3 inflammasome activation of epithe-
lial cells is followed by a compensatory
proliferative response.
In the related study in this issue of Immu-
nity, Dupaul-Chicoine et al. (2010) explore
the control of intestinal homeostasis by
inflammatory caspases, namely, cas-
pase-1 and caspase-12. These authors
also apply the model of DSS-induced
colitis. During acute colitis, Casp1/
mice are more susceptible whereas
the Casp12/ mice are comparable to
DSS-exposed WT mice. Interestingly,
Pycard/ mice reflected an intermediate
disease phenotype. Because the primary
defect in acute DSS colitis is found in
the epithelium, the epithelial integrity
was evaluated. Although no difference in
tight junction expression was revealed,
cell proliferation in Casp1/ mice
was decreased whereas it was in-
creased in Casp12/ mice. Accordingly,
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Figure 1. IL-18-Mediated Protective and Harmful Effects in Intestinal Inflammation
Depending on the site of activation, the release of IL-18 can present a mandatory protective mechanism or
exert the key mediator for intestinal destruction. After activation within the intestinal epithelial cells (IEC),
IL-18 contributes to the preservation of the intestinal barrier, mainly by inducing proliferation and thus
enhancing the regeneration of the damaged epithelium. Whether or not IL-18 is involved in the regulation
of antimicrobial peptides has not been addressed. In contrast, after activation in the lamina propria, IL-18
mainly in synergism with IL-12 exerts proinflammatory properties. This is followed by an infiltration of
neutrophils as well as an activation of effector T cells, thus sustaining the inflammatory cascade.
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PreviewsFITC-dextran permeability as well as
bacterial translocation was highest in
Casp1/ mice, whereas there was no
difference between WT and Pycard/
animals. The main IL-18-producing cell
population in DSS WT mice are IECs. The
protective role of IL-18 was underlined
by exogenous IL-18 administration that re-
sulted in protection ofCasp1/mice from
DSS colitis. In contrast to caspase-1, cas-
pase-12 is a dominant negative regulator
of caspase-1 and signaling by the intra-
cellular sensor NOD. Casp12/ mice
showed a comparable phenotype to WT
mice in the acute model of DSS colitis,
but expressed an increased mortality
when DSS exposure was prolonged to
15 days. Conflictingly, in the chronic
DSS model they were protected com-
pared to WT mice. In contrast, in the
AOM-DSS model a dramatic tumor bur-
den was observed in the Casp12/ mice
whereas only a few tumors were detected
in the AOM-DSS WT group. This was
associated with an overexpression of
the survival factor Bcl-xl, an increase in
cell proliferation, as well as more inflam-
mation and an infiltration of macrophages,
suggesting that the released mediators
promote tumor growth. Accordingly, DNA
microarray analysis of the tumors inCasp12/ mice revealed an upregulation
of proinflammatory as well as proliferative
genes.
Both papers conclude that in their
experimental setting IECs present the
relevant IL-18-producing cell population.
IL-18 is protective and furthermore re-
quired to maintain the epithelial integrity,
thus preventing the translocation of
bacteria and consequently death (Du-
paul-Chicoine et al., 2010; Zaki et al.,
2010). In the work from Zaki et al. (2010),
Nlrp3/ mice show a similar phenotype
as Casp1/ and Pycard/ mice, sug-
gesting that the Nlrp3 inflammasome
activation represents the key step in this
regulatory pathway. According to the
study by Dupaul-Chicoine et al. (2010),
an additional factor, namely caspase-12,
is involved. Caspase-12 acts by inhibiting
Nlrp3 activation. In the absence of cas-
pase-12, the mice are comparable to WT
mice in the acute DSS model; however,
they are more susceptible to the sus-
tained DSS exposure over 15 days. One
could argue that an overactivation of the
Nlrp3 inflammasome is rather deleterious.
However, in the chronic DSS model, they
are more protected but at the same time
more prone to tumor development in the
AOM-DSS model.Immunity 3Additional literature underlines the con-
cept that otherwise ‘‘proinflammatory’’
pathways are required for the epithelium
to guarantee the intestinal immune ho-
meostasis—acting as a physical barrier,
separating luminal bacteria and immune
cells, and also expressing antimicrobial
peptides. For instance, epithelial cell-
specific inhibition of NF-kB through con-
ditional ablation of NEMO spontaneously
caused severe chronic intestinal inflam-
mation (Nenci et al., 2007). NF-kB
deficiency led to apoptosis of IECs and
impaired antimicrobial peptide expres-
sion and translocation of bacteria into
the mucosa. Remarkably, deficiency of
MyD88 in the same mice prevented the
development of intestinal inflammation,
indicating that in the lamina propria
TLR activation by intestinal bacteria is
essential for disease pathogenesis (Nenci
et al., 2007).
The question remains whether IL-18 is
comparable to NF-kB proinflammatory
for the lamina propria. Recent genetic
work together with earlier experimental
data provide the answer and allow the
establishment of a working model. Auto-
phagy-related 16-like 1 (Atg16l1) has
been implicated in the pathogenesis of
Crohn’s disease; however, how autoph-
agy regulates inflammation was not
resolved. Autophagy presents a bulk
degradation system that controls the
degradation of long-lived proteins, insol-
uble protein aggregates, and invading
microbes. Mice lacking Atg16l1 solely in
hematopoietic cells are not only highly
susceptible to DSS-induced colitis but
furthermore, neutralizing antibodies to
either IL-1b or IL-18 in these mice resulted
in an amelioration of disease (Saitoh et al.,
2008). Looking back at the early functional
studies for IL-18, the anti-inflammatory
effect of neutralizing IL-18 was primarily
observed in the lamina propria (Kanai
et al., 2001; Siegmund et al., 2001). Kanai
et al. (2001) demonstrated the main
expression of IL-18 in their model in
macrophages of the lamina propria. Here
either deletion of macrophages or neutral-
izing IL-18 resulted in prevention of
disease (Kanai et al., 2001). This would
also allow for a clarification of the role of
caspase-12. In the absence of caspase-
12, one regulatory pathway of Nlrp3 in-
flammasome inhibition is missing, and
thus active IL-18 is available to maintain
the intestinal barrier at the level of IECs.2, March 26, 2010 ª2010 Elsevier Inc. 301
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PreviewsDuring the sustained DSS exposure, IL-18
affects the lamina propria and then the
deleterious effect of IL-18 dominates the
systems. During chronic DSS exposure,
there is enough time to recover, and the
caspase-12-meditated IEC proliferation
results in a sufficient regeneration that
becomes dangerous when the car-
cinogen enters the system. The working
model suggests that activation of Nlrp3
and IL-18 at the level of IEC is critical for
maintaining the intestinal homeostasis
and thus in the end the barrier against
bacterial translocation. In striking con-
trast, activation of Nlrp3 in the lamina
propria promotes intestinal inflammation.302 Immunity 32, March 26, 2010 ª2010 ElseREFERENCES
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Interleukin-17 (IL-17) is crucial for the progression of experimental autoimmune encephalomyelitis. In this
issue of Immunity, Kang et al. (2010) report that neuroectoderm-derived astrocytes are the critical cellular
element that responds to IL-17.Act1 is a crucial adaptor protein in the
interleukin-17 receptor (IL-17R) signaling
complex. Upon IL-17 binding, the hetero-
meric transmembrane receptor (IL-17RA
and IL-17RC) recruits and interacts with
Act1 by its SERIF domains (Chang et al.,
2006). A variety of cells express the
IL-17R signaling complex, facilitating
inflammatory responses to locally pro-
duced IL-17 in most tissues (Gaffen,
2009). IL-17-responsive cells are capable
of expanding local tissue inflammation
because IL-17 induces Act1-dependent
upregulation and mRNA stabilization of
proinflammatory cytokines and CXC
chemokines (Hartupee et al., 2007).
Several inflammatory autoimmune
disease models including experimental
autoimmune encephalomyelitis (EAE), a
mouse model of multiple sclerosis (MS),
have been shown to be mediated to a
substantial extent by Th17 cells, althoughboth Th1 and Th17 cells are capable of
inducing EAE individually, but probably
by different mechanisms and with dif-
ferent efficiency (Qian et al., 2007). As
previously reported (Qian et al., 2007),
mice deficient in Act1 exhibited delayed
onset and less severe myelin oligoden-
drocyte glycoprotein (MOG) peptide-in-
duced EAE. Given that there are multiple
stages and cell types involved in EAE
pathology, it was unclear at which stage
of disease pathogenesis IL-17, signaling
via Act1, was necessary, and it is this
question that was approached by Kang
et al. (2010) in this issue of Immunity.
EAE is a multistep inflammatory pro-
cess initiated by Th1 and Th17 cells. Dur-
ing actively induced EAE, myelin-specific
Th1 or Th17 cells are activated and ex-
pand in the peripheral lymphoid tissues
in response to myelin peptide and com-
plete Freund’s adjuvant (CFA) immuniza-tion. These activated T cells extravasate
across the blood brain barrier (BBB) sec-
ondary to interaction of very late activa-
tion antigen 4 (VLA-4) expressed on acti-
vated T cells with vascular cell adhesion
molecule (VCAM) expressed on cere-
brovascular endothelial cells (Yednock
et al., 1992). In the central nervous system
(CNS), infiltrating myelin-specific T cells
must be reactivated by brain-resident
antigen-presenting cells (including micro-
glia, macrophages, and myeloid dendritic
cells) presenting myelin antigen (Bailey
et al., 2007; Tompkins et al., 2002).
Release of Th1 or Th17 cell cytokines
induced by this interaction results in local
inflammation and demyelination of white
matter tracts, reducing the ability of axons
to conduct electrical signals and eventu-
ally neuronal transection. Astrocytes are
involved in nearly all processes within
the brain, but their contribution to EAE
